Eidelman Virant Capital - CORCEPT THERAPEUTICS INC ownership

CORCEPT THERAPEUTICS INC's ticker is CORT and the CUSIP is 218352102. A total of 159 filers reported holding CORCEPT THERAPEUTICS INC in Q2 2017. The put-call ratio across all filers is 0.38 and the average weighting 0.2%.

Quarter-by-quarter ownership
Eidelman Virant Capital ownership history of CORCEPT THERAPEUTICS INC
ValueSharesWeighting
Q3 2018$140,000
-10.8%
10,0000.0%0.07%
-28.9%
Q2 2018$157,000
-76.1%
10,000
-75.0%
0.10%
-77.4%
Q1 2018$658,000
-8.9%
40,0000.0%0.43%
+1.7%
Q4 2017$722,0000.0%40,0000.0%0.42%
-1.4%
Q3 2017$722,000
+17.8%
40,000
-23.1%
0.43%
+21.5%
Q2 2017$613,00052,0000.35%
Other shareholders
CORCEPT THERAPEUTICS INC shareholders Q2 2017
NameSharesValueWeighting ↓
INGALLS & SNYDER LLC 8,340,193$227,22910.94%
Novo Holdings A/S 3,377,768$92,044,1786.80%
Parallel Advisors, LLC 3,723,483$101,446,2943.38%
TANAKA CAPITAL MANAGEMENT INC 37,569$1,0242.92%
S&T BANK/PA 334,252$9,1071.76%
Birchview Capital, LP 50,000$1,362,2501.16%
Granite Investment Partners, LLC 798,552$21,756,5490.91%
FAS Wealth Partners, Inc. 310,764$8,466,7660.90%
Clearview Wealth Advisors LLC 25,258$688,1550.85%
Bridge City Capital, LLC 43,485$1,184,7490.60%
View complete list of CORCEPT THERAPEUTICS INC shareholders